Purple Biotech PPBT
NASDAQ PPBT
$1.74 -0.10 (-5.43%)
At close: Sep 10, 2026 · 4:00 PM EDT

Purple Biotech (PPBT) Acquisitions (2023)

Purple Biotech's (PPBT) quarterly Acquisitions came in at -$3.5 million in Q1 2023.

Analysis

Purple Biotech (PPBT) Acquisitions (2023) Analysis & Trends

Purple Biotech (PPBT) has reported Acquisitions for 1 consecutive years, with -$3.5 million the latest figure, recorded in Q1 2023.

  • On a quarterly basis, Acquisitions changed N/A year-over-year to -$3.5 million in Q1 2023; TTM through Dec 2023 was -$3.5 million, a N/A change from a year earlier, with the FY2023 full-year figure at -$3.5 million, changed N/A from the prior year.
  • Acquisitions was -$3.5 million for Q1 2023 at Purple Biotech.
  • Over five years, Acquisitions peaked at -$3.5 million in Q1 2023 and troughed at -$3.5 million in Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 11.21 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn -
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn -
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Purple Biotech 295,122.59 295,122.59 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -3.55 Mn